Elevated Postoperative Endogenous GLP-1 Levels Mediate Effects of Roux-en-Y Gastric Bypass on Neural Responsivity to Food Cues
Author(s) -
Jennifer S. ten Kulve,
Dick J. Veltman,
Victor E. A. Gerdes,
Liselotte van Bloemendaal,
Frederik Barkhof,
Carolyn F. Deacon,
Jens J. Holst,
Madeleine L. Drent,
Michaëla Diamant,
Richard G. IJzerman
Publication year - 2017
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc16-2113
Subject(s) - medicine , appetite , glucagon like peptide 1 , endocrinology , peptide yy , blockade , ingestion , receptor , neuropeptide y receptor , neuropeptide , type 2 diabetes , diabetes mellitus
It has been suggested that weight reduction and improvements in satiety after Roux-en-Y gastric bypass (RYGB) are partly mediated via postoperative neuroendocrine changes. Glucagon-like peptide-1 (GLP-1) is a gut hormone secreted after food ingestion and is associated with appetite and weight reduction, mediated via effects on the central nervous system (CNS). Secretion of GLP-1 is greatly enhanced after RYGB. We hypothesized that postoperative elevated GLP-1 levels contribute to the improved satiety regulation after RYGB via effects on the CNS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom